{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:48:00Z","timestamp":1751359680674},"reference-count":40,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Laryngorhinootologie"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\n          Hintergrund\u2002Die chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) ist eine multifaktorielle entz\u00fcndliche Erkrankung der Schleimh\u00e4ute von Nase und Nasennebenh\u00f6hlen. Eine Typ-2-Inflammation als immunologischer Mechanismus wird als h\u00e4ufigster Endotyp beschrieben. Der Anti-IL-4-\/-IL-13-Antik\u00f6rper Dupilumab ist seit Oktober 2019 als Zusatztherapie zu intranasalen Glukokortikosteroiden f\u00fcr die Behandlung Erwachsener mit schwerer chronischer Rhinosinusitis mit Nasenpolypen zugelassen, wenn systemische Glukokortikosteroide oder eine Operation keine ausreichende Krankheitskontrolle bewirken. W\u00e4hrend nationale und internationale Empfehlungen f\u00fcr den Einsatz von Dupilumab bei CRSwNP existieren, ist bislang nicht hinreichend festgelegt worden, wie diese Therapie \u00fcberwacht und wann sie ggf. beendet werden sollte.<\/jats:p><jats:p>\n          Methoden\u2002In einer Literatursuche wurden die bisherigen Daten zur Behandlung der CRSwNP mit Dupilumab analysiert und die vorhandene Evidenz durch Recherchen in MEDLINE, PubMed sowie den nationalen und internationalen Studien- und Leitlinienregistern und der Cochrane Library ermittelt. Es wurden Humanstudien ber\u00fccksichtigt, die im Zeitraum bis einschlie\u00dflich 05\/2022 publiziert wurden.<\/jats:p><jats:p>\n          Ergebnis\u2002Basierend auf der internationalen Literatur und bisherigen Erfahrungen werden von einem Expertengremium Empfehlungen f\u00fcr die Verlaufskontrolle, das Einhalten von Therapieintervallen und eventuelle Therapiepausen sowie eine Beendigung der Therapie bei Anwendung von Dupilumab f\u00fcr die Indikation CRSwNP im deutschen Gesundheitssystem auf der Grundlage eines Dokumentationsbogens gegeben.<\/jats:p><jats:p>\n          Schlussfolgerungen\u2002Das Verst\u00e4ndnis \u00fcber die immunologischen Grundlagen der CRSwNP er\u00f6ffnet neue nichtoperative Therapieans\u00e4tze mit Biologika f\u00fcr Patienten mit schweren, unkontrollierten Verlaufsformen. Wir geben hier Empfehlungen f\u00fcr die Verlaufskontrolle, das Einhalten von Therapieintervallen, eventuelle Therapiepausen oder eine Beendigung der Therapie bei einer Dupilumab-Behandlung als Zusatztherapie mit intranasalen Glukokortikosteroiden zur Behandlung von erwachsenen Patienten mit schwerer CRSwNP, die mit systemischen Glukokortikosteroiden und\/oder chirurgischem Eingriff nicht ausreichend kontrolliert werden k\u00f6nnen.<\/jats:p>","DOI":"10.1055\/a-1908-3074","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T23:26:48Z","timestamp":1663975608000},"page":"855-865","source":"Crossref","is-referenced-by-count":7,"title":["Empfehlungen zur \u00dcberpr\u00fcfung der Wirksamkeit und Verlaufsdokumentation von Dupilumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem"],"prefix":"10.1055","volume":"101","author":[{"given":"L.","family":"Klimek","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Rhinologie und Allergologie, Wiesbaden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"F\u00f6rster-Ruhrmann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Charit\u00e9-Universit\u00e4tsmedizin Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Olze","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Charit\u00e9-Universit\u00e4tsmedizin Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Beule","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum M\u00fcnster"},{"name":"Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie der Universit\u00e4tsmedizin Greifswald"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Chaker","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, TUM School of Medicine, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen"},{"name":"Zentrum f\u00fcr Allergie und Umwelt (ZAUM), TUM School of Medicine, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hagemann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsmedizin Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Huppertz","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsmedizin Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. K.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Ulm"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dazert","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Ruhr-Universit\u00e4t Bochum, St. Elisabeth-Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Deitmer","sequence":"additional","affiliation":[{"name":"Deutsche Gesellschaft f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie, Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Strieth","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Hals-, Nasen-, Ohren-Heilkunde, Universit\u00e4tsklinikum Bonn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wrede","sequence":"additional","affiliation":[{"name":"Hals-, Nasen- und Ohrenarzt, Herford"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Schlenter","sequence":"additional","affiliation":[{"name":"\u00c4rzteverband Deutscher Allergologen, Wiesbaden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Welkoborsky","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Klinikum Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wollenberg","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, TUM School of Medicine, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Becker","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinik T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Klimek","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Rhinologie und Allergologie, Wiesbaden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sperl","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Rhinologie und Allergologie, Wiesbaden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Casper","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Rhinologie und Allergologie, Wiesbaden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zuberbier","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Charit\u00e9-Universit\u00e4tsmedizin Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rudack","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum M\u00fcnster"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cuevas","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr HNO-Heilkunde, Universit\u00e4tsklinikum Carl Gustav Carus, TU Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Hintschich","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Hals-Nasen-Ohren-Heilkunde, Universit\u00e4tsklinikum Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Guntinas-Lichius","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Jena"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"St\u00f6ver","sequence":"additional","affiliation":[{"name":"Universit\u00e4ts-Hals-Nasen-Ohrenklinik Frankfurt am Main"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Praxis f\u00fcr Hals-, Nasen-, Ohrenheilkunde, Klinik RKM 740, D\u00fcsseldorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Pfaar","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gosepath","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, HSK Wiesbaden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gr\u00f6ger","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Beutner","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Dermatologie, Venerologie und Allergologie, Universit\u00e4tsmedizin G\u00f6ttingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Laudien","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie der Christian-Albrechts-Universit\u00e4t zu Kiel und des Universit\u00e4tsklinikums Schleswig-Holstein, Campus Kiel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. K.","family":"Weber","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, St\u00e4dtisches\u00a0Klinikum Karlsruhe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hildenbrand","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Hamburg-Eppendorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bachert","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Hals-, Nasen- und Ohrenheilkunde, Universit\u00e4tsklinikum Gent, Belgien"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/all.14809","article-title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines","volume":"76","author":"I Agache","year":"2021","journal-title":"Allergy"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s40629-017-0048-5","article-title":"Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities","volume":"27","author":"M Koennecke","year":"2018","journal-title":"Allergo journal international"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management","volume":"147","author":"C Bachert","year":"2020","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"S 29","key":"ref4","first-page":"1","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"W J Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"09","key":"ref5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/all.13162","article-title":"Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis \u2013 A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement","volume":"72","author":"P W Hellings","year":"2017","journal-title":"Allergy"},{"issue":"01","key":"ref6","first-page":"38","article-title":"[Guideline for \u201crhinosinusitis\u201d-long version: S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery]","volume":"66","author":"B A Stuck","year":"2018","journal-title":"HNO"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1055\/a-1240-9304","article-title":"Positionspapier: Hinweise zur Patienteninformation und -aufkl\u00e4rung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC) \u2013 Teil 1: Dupilumab","volume":"99","author":"L Klimek","year":"2020","journal-title":"Laryngo-Rhino-Otol"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/a-1197-0136","article-title":"Positionspapier: Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)","volume":"99","author":"L Klimek","year":"2020","journal-title":"Laryngo-Rhino-Otol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1055\/a-1592-0316","article-title":"Positionspapier: Hinweise zur Patienteninformation und -aufkl\u00e4rung vor Anwendung von Biologika bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) \u2013 Teil 2: Omalizumab \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)","volume":"100","author":"U F\u00f6rster-Ruhrmann","year":"2021","journal-title":"Laryngo-Rhino-Otol"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1055\/a-1644-4066","article-title":"Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)","volume":"100","author":"L Klimek","year":"2021","journal-title":"Laryngo-Rhino-Otol"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/a-1752-8462","article-title":"Positionspapier: Empfehlungen zur Anwendung von Mepolizumab bei chronischer RhinoSinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der AG\u02bcs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)","volume":"101","author":"L Klimek","year":"2022","journal-title":"Laryngo-Rhino-Otol"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/a-1164-9696","article-title":"Positionspapier: Empfehlungen zur Behandlung der chronischen Rhinosinusitis w\u00e4hrend der COVID-19-Pandemie im deutschen Gesundheitssystem \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) \u2013 Diese Empfehlungen basieren auf dem EAACI Positionspapier \u201cTreatment of chronic RhinoSinusitis with nasal polyps (CRSwNP) in the COVID-19 pandemics \u2013 An EAACI Position Paper\u201d, Allergy, 2020 und wurden auf die Situation im deutschen Gesundheitswesen angepasst","volume":"99","author":"L Klimek","year":"2020","journal-title":"Laryngo-Rhino-Otol"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2500\/ajra.2013.27.3981","article-title":"Epidemiology and differential diagnosis of nasal polyps","volume":"27","author":"M R Chaaban","year":"2013","journal-title":"American journal of rhinology & allergy"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00005537-200405000-00004","article-title":"Recurrence rates after endoscopic sinus surgery for massive sinus polyposis","volume":"114","author":"R Wynn","year":"2004","journal-title":"The Laryngoscope"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2500\/ajra.2014.28.4024","article-title":"The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study","volume":"28","author":"S Vlaminck","year":"2014","journal-title":"American journal of rhinology & allergy"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis","volume":"12","author":"R P Schleimer","year":"2016","journal-title":"Annual review of pathology"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-015-0579-0","article-title":"Immune Mechanisms of Chronic Rhinosinusitis","volume":"16","author":"K E Hulse","year":"2016","journal-title":"Current allergy and asthma reports"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"A Blauvelt","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12325-018-0702-4","article-title":"Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy\/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma","volume":"35","author":"W W Busse","year":"2018","journal-title":"Adv Ther"},{"issue":"26","key":"ref20","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma","volume":"378","author":"M Castro","year":"2018","journal-title":"The New England journal of medicine"},{"issue":"26","key":"ref21","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma","volume":"378","author":"K F Rabe","year":"2018","journal-title":"The New England journal of medicine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/a-1200-1830","article-title":"Eosinophilie unter Dupilumab bei chronischer Rhinosinusitis mit Polyposis nasi und Asthma bronchiale","author":"L Klimek","year":"2020","journal-title":"Laryngo-Rhino-Otol"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12348-020-00234-y","article-title":"Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy","volume":"11","author":"A Kimura","year":"2021","journal-title":"Journal of ophthalmic inflammation and infection"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.019","article-title":"Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis","author":"M E Wechsler","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial","volume":"315","author":"C Bachert","year":"2016","journal-title":"Jama"},{"issue":"05","key":"ref27","first-page":"2433","article-title":"Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study","volume":"279","author":"T Albrecht","year":"2021","journal-title":"European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology \u2013 Head and Neck Surgery"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/all.13984","article-title":"Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis","author":"C Bachert","year":"2019","journal-title":"Allergy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"C Bachert","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s00106-021-01018-z","article-title":"Dupilumab besitzt einen Zusatznutzen f\u00fcr die Behandlung der chronischen Rhinosinusitis mit Nasenpolypen","volume":"69","author":"L Klimek","year":"2021","journal-title":"Hno"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40463-022-00570-0","article-title":"Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps","volume":"51","author":"S J Kilty","year":"2022","journal-title":"Journal of otolaryngology \u2013 head & neck surgery = Le Journal d\u2019oto-rhino-laryngologie et de chirurgie cervico-faciale"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/chemse\/22.1.39","article-title":"\u201cSniffin\u2019 sticks\u201d: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold","volume":"22","author":"T Hummel","year":"1997","journal-title":"Chemical senses"},{"issue":"03","key":"ref33","first-page":"719","article-title":"Updated Sniffin\u2019 Sticks normative data based on an extended sample of 9139 subjects","volume":"276","author":"A Oleszkiewicz","year":"2018","journal-title":"European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology \u2013 Head and Neck Surgery"},{"issue":"03","key":"ref34","first-page":"237","article-title":"Normative data for the \u201cSniffin\u2019 Sticks\u201d including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3000 subjects","volume":"264","author":"T Hummel","year":"2007","journal-title":"European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology \u2013 Head and Neck Surgery"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1097\/01.mlg.0000234915.51189.cb","article-title":"Clinical significance of results from olfactory testing","volume":"116","author":"V Gudziol","year":"2006","journal-title":"The Laryngoscope"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/all.15379","article-title":"Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations","author":"M Lommatzsch","year":"2022","journal-title":"Allergy"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2\u00a0randomized phase 3 trials","volume":"146","author":"P Gevaert","year":"2020","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/alr.22936","article-title":"Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps","volume":"12","author":"A K Parasher","year":"2022","journal-title":"International forum of allergy & rhinology"},{"issue":"01","key":"ref39","first-page":"E26","article-title":"Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps","volume":"131","author":"G A Scangas","year":"2020","journal-title":"The Laryngoscope"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40629-022-00220-x","article-title":"Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP) \u2013 Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, and mepolizumab","volume":"31","author":"L Klimek","year":"2022","journal-title":"Allergo J Int"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/all.15134","article-title":"Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"77","author":"R JL van der Lans","year":"2021","journal-title":"Allergy"}],"container-title":["Laryngo-Rhino-Otologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1908-3074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:22:33Z","timestamp":1667521353000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1908-3074"}},"subtitle":["Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)"],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,3]]},"published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1908-3074","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0935-8943","1438-8685"],"issn-type":[{"value":"0935-8943","type":"print"},{"value":"1438-8685","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}